Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm

Parkinsonism and Related Disorders

Volumn 10, Issue 7, 2004, Pages 455-456

  Tousi, Babak ^a   Perumal, Jai S ^a   Ahuja, Kanwaljit ^a   Ahmed, Anwar ^a   Subramanian, Thyagarajan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Blepharospasm; Botulinum toxin; Chemodenervation; Hemifacial spasm; Orbiculis oculi

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; HEMIFACIAL SPASM; HUMAN; LETTER; PRIORITY JOURNAL; SEROLOGY; SIDE EFFECT;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; HEMIFACIAL SPASM; HUMANS; MIDDLE AGED;

EID: 4644232326     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2004.03.003     Document Type: Letter

References (4)

1. Jankovic J., Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 45:1995;1743-1746
2. Brashear A., Lew M.F., Dykstra D.D., Comella C.L., Factor S.A., Rodnitzky R.L., Trosch R., Singer C., Brin M.F., Murray J.J., Wallace J.D., Willmer-Hulme A., Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology. 53:1999;1439-1446
3. Brin M.F., Lew M.F., Adler C.H., Comella C.L., Factor S.A., Jankovic J., O'Brien C., Murray J.J., Wallace J.D., Willmer-Hulme A., Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology. 53:1999;1431-1438
4. Lew M.F., Adornato B.T., Duane D.D., Dykstra D.D., Factor S.A., Massey J.M., Brin M.F., Jankovic J., Rodnitzky R.L., Singer C., Swenson M.R., Tarsy D., Murray J.J., Koller M., Wallace J.D. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 49:1997;701-707